Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Phase I Oncology Trials
100%
Drug Toxicity
100%
Nomogram
100%
Phase I Trial
50%
Concordance Index
25%
Solid Tumors
12%
Hematologic
12%
High Risk
12%
Evaluation Program
12%
Bootstrap
12%
Therapeutic Drug Monitoring
12%
Clinical Significance
12%
Albumin
12%
Significant Predictors
12%
Logistic Regression
12%
Statistical Significance
12%
Final Model
12%
Multiple Covariates
12%
Non-biological
12%
Creatinine Clearance
12%
Cancer Therapeutics
12%
WBC Count
12%
Bootstrapping Method
12%
Patient Risk
12%
Eastern Cooperative Oncology Group Performance Status (ECOG PS)
12%
Nursing and Health Professions
Nomogram
100%
Leukocyte Count
16%
Program Evaluation
16%
Malignant Neoplasm
16%
Solid Malignant Neoplasm
16%
Logistic Regression Analysis
16%
Creatinine Clearance
16%
Bootstrapping
16%
Albumin
16%
Accident Prevention
16%
Biochemistry, Genetics and Molecular Biology
Nomogram
100%
Phase I Trials
66%
Leukocyte Count
16%
Creatinine Clearance
16%
Albumin
16%
Pharmacology, Toxicology and Pharmaceutical Science
Phase I Trials
100%
Malignant Neoplasm
25%
Solid Malignant Neoplasm
25%
Creatinine
25%
Albumin
25%
Neuroscience
Nomogram
100%
Creatinine
16%
Albumin
16%
Leukocyte
16%